Switch to:
More From Other Websites
AbbVie: Here's How It Could Differentiate Itself From Gilead Dec 18 2014
AbbVie Pins Hopes on Hepatitis C Treatment Dec 18 2014
Shire considering bid for NPS Pharmaceuticals - Bloomberg Dec 17 2014
Shire considering bid for NPS Pharmaceuticals - Bloomberg Dec 17 2014
Shire Said to Weigh Offer for NPS as It Revisits Deals Dec 17 2014
Viekirax/Exviera vs. Harvoni: Clash of the Hep C Drugs 2015 Dec 16 2014
Will AbbVie Undercut Gilead on Hepatitis C? Dec 11 2014
Analysts' Actions: AbbVie, Ariad, Lilly, Prologis, Toll Brothers Dec 11 2014
Gilead Is Growing Fast And Its Stock Is Cheap Dec 11 2014
Walgreens CEO announces plans to step down Dec 10 2014
AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH (Revised) Dec 10 2014
Gilead Sciences: Still Waiting on AbbVie Dec 09 2014
AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH Dec 08 2014
AbbVie Presents Results from Phase 2 Study of Investigational Compound Venetoclax (ABT-199/GDC-0199)... Dec 07 2014
AbbVie Presents Results from Phase 2 Study of Investigational Compound Venetoclax (ABT-199/GDC-0199)... Dec 07 2014
Abbott Labs attracts bullish trades Dec 03 2014
Bullish Options Buyers Are Turning to Abbott Laboratories Dec 03 2014
Meet 5 Top Drug Stocks That Are Bolting Past Market Dec 02 2014
AbbVie, Intel, Sony, BCE : Intellectual Property Dec 02 2014
Large Cap All-Time Highs List... Dec 01 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK